title: CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes.
abstract: Although numerous reports document a role for CD43 in T cell signaling, the direct participation of this molecule in cell activation has been questioned. In this study we show that CD43 ligation on human normal peripheral T cells was sufficient to induce interleukin-2, CD69, and CD40-L gene expression, without requiring signals provided by additional receptor molecules. This response was partially inhibited by cyclosporin A and staurosporine, suggesting the participation of both the Ca(2+) and the protein kinase C pathways in CD43 signaling. Consistent with the transient CD43-dependent intracellular Ca(2+) peaks reported by others, signals generated through the CD43 molecule resulted in the induction of NF-AT DNA binding activity. CD43-dependent signals resulted also in AP-1 and NFkappaB activation, probably as a result of protein kinase C involvement. AP-1 complexes bound to the AP-1 sequence contained c-Jun, and those bound to the NF-AT-AP-1 composite site contained c-Jun and Fos. NFkappaB complexes containing p65 could be found as early as 1 h after CD43 cross-linking, suggesting that CD43 participates in early events of T cell activation. The induction of the interleukin-2, CD69, and CD-40L genes and the participation of AP-1, NF-AT, and NFkappaB in the CD43-mediated signaling cascade implicate an important role for this molecule in the regulation of gene expression and cell function.
authors.affiliation: Instituto de Biotecnologia/Universidad Nacional Autónoma de México, Apartado Postal 510-3 Cuernavaca, Morelos 62250, México.
authors.forename: M A
authors.initials: MA
authors.lastname: Santana
authors.forename: G
authors.initials: G
authors.lastname: Pedraza-Alva
authors.forename: N
authors.initials: N
authors.lastname: Olivares-Zavaleta
authors.forename: V
authors.initials: V
authors.lastname: Madrid-Marina
authors.forename: V
authors.initials: V
authors.lastname: Horejsi
authors.forename: S J
authors.initials: SJ
authors.lastname: Burakoff
authors.forename: Y
authors.initials: Y
authors.lastname: Rosenstein
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D000945:Antigens, Differentiation, T-Lymphocyte / Q000378:metabolism; D023201:CD40 Ligand / Q000378:metabolism; D065095:Calcineurin Inhibitors; D002118:Calcium / Q000378:metabolism; D002135:Calcium-Binding Proteins; D002467:Cell Nucleus / Q000378:metabolism; D003432:Cross-Linking Reagents / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D004247:DNA / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005786:Gene Expression Regulation; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism; D007477:Ions; D019169:Jurkat Cells; D037181:Lectins, C-Type; D051917:Leukosialin; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000378:metabolism; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism*; D050778:NFATC Transcription Factors; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009687:Nuclear Proteins; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D016755:Proto-Oncogene Proteins c-jun / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012795:Sialoglycoproteins / Q000378:metabolism*; D015398:Signal Transduction; D019311:Staurosporine / Q000494:pharmacology; D050863:Synaptotagmin I; D050857:Synaptotagmins; D013601:T-Lymphocytes / Q000378:metabolism; D013997:Time Factors; D018808:Transcription Factor AP-1 / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D000099192:CD69 Antigens
chemical_list: D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D023201:CD40 Ligand; D065095:Calcineurin Inhibitors; D002118:Calcium; D002135:Calcium-Binding Proteins; D003432:Cross-Linking Reagents; D016572:Cyclosporine; D004247:DNA; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D007376:Interleukin-2; D007477:Ions; D037181:Lectins, C-Type; D051917:Leukosialin; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D050778:NFATC Transcription Factors; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D011493:Protein Kinase C; D016760:Proto-Oncogene Proteins c-fos; D016755:Proto-Oncogene Proteins c-jun; D012333:RNA, Messenger; D012795:Sialoglycoproteins; D019311:Staurosporine; D050863:Synaptotagmin I; D050857:Synaptotagmins; D018808:Transcription Factor AP-1; D014157:Transcription Factors; D000099192:CD69 Antigens; C465014:SPN protein, human